T1	CHEM 58 68	ECULIZUMAB
#1	AnnotatorNotes T1	C1541483; eculizumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T2	DISO 86 114	MIASTENIA GRAVE GENERALIZADA
T3	PROC 155 227	ESTUDIO MULTICENTRICO, ALEATORIZADO, DOBLE CIEGO, CONTROLADO CON PLACEBO
T4	DISO 330 333	MGG
T5	PROC 234 268	EVALUAR LA EFICACIA Y LA SEGURIDAD
#2	AnnotatorNotes T5	C0511730; Identify product efficacy and safety issues; Health Care Activity
T6	CHEM 272 282	ECULIZUMAB
#3	AnnotatorNotes T6	C1541483; eculizumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T7	DISO 300 328	MIASTENIA GRAVE GENERALIZADA
T8	DISO 370 385	miastenia grave
#4	AnnotatorNotes T8	C0026896; Myasthenia Gravis; Disease or Syndrome
T9	DISO 412 440	miastenia grave generalizada
T10	PROC 528 539	Diagnóstico
#5	AnnotatorNotes T10	C0011900; Diagnosis; Diagnostic Procedure
T11	DISO 728 734	timoma
#6	AnnotatorNotes T11	C0040100; Thymoma; Neoplastic Process
T12	DISO 743 762	neoplasias del timo
#7	AnnotatorNotes T12	C3714644; Thymus Neoplasms; Neoplastic Process
T13	PROC 782 792	timectomía
#8	AnnotatorNotes T13	C0040071; Thymectomy; Therapeutic or Preventive Procedure
T14	DISO 843 852	Debilidad
#9	AnnotatorNotes T14	C0424594; Frailty; Finding | C3714552; Weakness; Sign or Symptom
T15	ANAT 881 898	músculos oculares
T16	DISO 543 545	MG
T17	DISO 937 949	Crisis de MG
#10	AnnotatorNotes T17	C0270942; Myasthenic crisis; Disease or Syndrome
T18	DISO 1012 1035	Infección meningocócica
#11	AnnotatorNotes T18	C0025303; Meningococcal Infections; Disease or Syndrome
T19	DISO 442 445	MGg
T20	ANAT 758 762	timo
#12	AnnotatorNotes T20	C0040113; Thymus Gland; Body Part, Organ, or Organ Component
T21	DISO 116 119	MGG
T22	Date 13 17	2013
T23	LIVB 72 81	PACIENTES
#13	AnnotatorNotes T23	C0030705; Patients; Patient or Disabled Group
T24	LIVB 286 295	PACIENTES
#14	AnnotatorNotes T24	C0030705; Patients; Patient or Disabled Group
T25	LIVB 487 496	pacientes
#15	AnnotatorNotes T25	C0030705; Patients; Patient or Disabled Group
T26	Age 497 506	≥ 18 años
T27	LIVB 508 515	hombres
#16	AnnotatorNotes T27	C0025266; Male population group; Population Group
T28	LIVB 518 525	mujeres
#17	AnnotatorNotes T28	C0043210; Woman; Population Group
T30	Duration 810 818	12 meses
T31	PHYS 989 997	Embarazo
#18	AnnotatorNotes T31	C0032961; Pregnancy; Organism Function
T32	PHYS 1000 1009	lactancia
#19	AnnotatorNotes T32	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T33	LIVB 1022 1035	meningocócica
#20	AnnotatorNotes T33	C0027575; Neisseria meningitidis; Bacterium
A1	Status T11 History_of
A2	Status T12 History_of
A3	Status T13 History_of
#21	AnnotatorNotes T4	C0751339; Myasthenia Gravis, Generalized; Disease or Syndrome 
#22	AnnotatorNotes T16	C0026896; Myasthenia Gravis; Disease or Syndrome
#23	AnnotatorNotes T3	C1096776; Multicenter Study; Research Activity + C0034656; Randomization; Research Activity + C0013072; Double-Blind Method; Research Activity + C0599724; placebo controlled study; Research Activity · Intellectual Product 
#24	AnnotatorNotes T2	C0751339; Myasthenia Gravis, Generalized; Disease or Syndrome 
#25	AnnotatorNotes T21	C0751339; Myasthenia Gravis, Generalized; Disease or Syndrome 
#26	AnnotatorNotes T7	C0751339; Myasthenia Gravis, Generalized; Disease or Syndrome 
#27	AnnotatorNotes T9	C0751339; Myasthenia Gravis, Generalized; Disease or Syndrome 
#28	AnnotatorNotes T19	C0751339; Myasthenia Gravis, Generalized; Disease or Syndrome 
T29	Neg_cue 1036 1038	no
T34	Observation 1039 1047	resuelta
A4	Assertion T34 Negated
#29	AnnotatorNotes T34	C1709863; Recovered or Resolved; Finding
R1	Experiences Arg1:T23 Arg2:T1	
R2	Experiences Arg1:T23 Arg2:T2	
R3	Experiences Arg1:T23 Arg2:T21	
T35	Quantifier_or_Qualifier 121 132	REFRACTARIA
#30	AnnotatorNotes T35	C0205269; Unresponsive to Treatment; Functional Concept
R4	Has_Quantifier_or_Qualifier Arg1:T21 Arg2:T35	
R5	Has_Quantifier_or_Qualifier Arg1:T2 Arg2:T35	
T36	Quantifier_or_Qualifier 335 346	REFRACTARIA
R6	Has_Quantifier_or_Qualifier Arg1:T4 Arg2:T36	
R7	Has_Quantifier_or_Qualifier Arg1:T7 Arg2:T36	
R8	Experiences Arg1:T24 Arg2:T6	
R9	Experiences Arg1:T24 Arg2:T7	
R10	Experiences Arg1:T24 Arg2:T4	
R11	Has_Age Arg1:T25 Arg2:T26	
R12	Has_Age Arg1:T27 Arg2:T26	
R13	Has_Age Arg1:T28 Arg2:T26	
T37	Result_or_Value 548 561	Clase II a IV
T38	CONC 568 600	clasificación clínica de la MGFA
#31	AnnotatorNotes T38	C3828873; Myasthenia Classification System; Intellectual Product ['Myasthenia Gravis Foundation of America']
R14	Has_Result_or_Value Arg1:T38 Arg2:T37	
T39	PROC 607 616	selección
#32	AnnotatorNotes T39	C0242802; Patient Selecton; Research Activity
R15	Overlap Arg1:T38 Arg2:T39	
T40	PROC 674 683	selección
#33	AnnotatorNotes T40	C0242802; Patient Selecton; Research Activity
T41	Result_or_Value 664 667	≥ 6
T42	CONC 646 652	MG-ADL
#34	AnnotatorNotes T42	['Myasthenia Gravis Activities of Daily Living']
R16	Has_Result_or_Value Arg1:T42 Arg2:T41	
R17	Overlap Arg1:T42 Arg2:T40	
R18	Location_of Arg1:T20 Arg2:T12	
R19	Overlap Arg1:T13 Arg2:T30	
T43	PROC 831 840	selección
#35	AnnotatorNotes T43	C0242802; Patient Selecton; Research Activity
R20	Before Arg1:T13 Arg2:T43	
T44	Quantifier_or_Qualifier 857 867	únicamente
R21	Location_of Arg1:T15 Arg2:T14	
R22	Has_Quantifier_or_Qualifier Arg1:T15 Arg2:T44	
T45	Result_or_Value 915 922	clase I
T46	CONC 929 933	MGFA
#36	AnnotatorNotes T46	C3828873; Myasthenia Classification System; Intellectual Product ['Myasthenia Gravis Foundation of America']
R23	Has_Result_or_Value Arg1:T46 Arg2:T45	
T47	ANAT 881 889;901 913	músculos perioculares
#37	AnnotatorNotes T15	C0935613; Ocular muscle; Body Part, Organ, or Organ Component
R24	Location_of Arg1:T47 Arg2:T14	
R25	Has_Quantifier_or_Qualifier Arg1:T47 Arg2:T44	
T48	CONC 981 985	MGFA
#38	AnnotatorNotes T48	C3828873; Myasthenia Classification System; Intellectual Product ['Myasthenia Gravis Foundation of America']
T49	Result_or_Value 967 974	clase V
R26	Has_Result_or_Value Arg1:T48 Arg2:T49	
T50	PROC 956 965	selección
#39	AnnotatorNotes T50	C0242802; Patient Selecton; Research Activity
R27	Overlap Arg1:T17 Arg2:T50	
R28	Causes Arg1:T33 Arg2:T18	
R29	Negation Arg1:T29 Arg2:T34	
R30	Before Arg1:T18 Arg2:T34	
R31	Location_of Arg1:T20 Arg2:T11	
#40	AnnotatorNotes T36	C0205269; Unresponsive to Treatment; Functional Concept
#41	AnnotatorNotes T44	C0205171; Singular; Quantitative Concept
A5	Experiencer T23 Patient
A6	Experiencer T24 Patient
A7	Experiencer T25 Patient
A8	Experiencer T27 Patient
A9	Experiencer T28 Patient
